Maria Gabriela Pedigoni Bulisani

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background Glycemic control is critical for in-patients and dysglycemia is associated with worse prognosis and higher mortality. Insulin therapy is considered the best treatment on this scenario and basal insulin analogues, such as insulin glargine (IGlar) and IDeg, could be useful options, however there are no studies comparing IGlar and IDeg evaluating(More)
  • 1